MSH2 and colorectal carcinoma: In Puerto Rico, a population-based study conducted by de Jesus-Monge et al. [35] reported that the prevalence of deficient MMR protein expression (MLH1 and MSH2) among CRC patients was 4.3% with most cases having absence of MSH2 proteins.